The company reported revenue of $37,732 with a net loss of -$426,934 and EPS of -$0. This indicates significant financial distress, with losses far outweighing revenue. The negative EPS further exacerbates the negative financial outlook.
Analysis Details
AI-POWERED INSIGHTSSourceNUTRA PHARMA CORP
PublishedDecember 17, 2025 at 10:08 PM Fresh - Highly Relevant
AI Confidence90% High
ImplicationPotential headwinds for related securities
Disclaimer: This analysis is for informational purposes only and should not be considered financial advice. Always consult with a qualified financial advisor before making investment decisions.